§ Funding Round
Series D funding round for MapLight Therapeutics raising $370M in July 2025
Series D funding round for MapLight Therapeutics raising $370M in July 2025
| Investor | Firm Type | Partner |
|---|---|---|
EQT Life Sciences | — | — |
ForbionLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
T. Rowe Price Associates | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$600M
Top Valuation
-
MapLight Therapeutics raised $370M in a Series D round.
The round was announced on 07/01/25.
The round was led by Forbion.
